River & Mercantile Asset Management LLP Moderna, Inc. Transaction History

River & Mercantile Asset Management LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$85.37 - $115.44 $3,158 - $4,271	-37 Reduced 1.03%	3,539 $377,000
Q4 2023 Feb 06, 2024	SELL	$69.51 - $104.43 $147,778 - $222,018	-2,126 Reduced 37.29%	3,576 $355,000
Q3 2023 Nov 13, 2023	SELL	$96.41 - $126.61 $25,837 - $33,931	-268 Reduced 4.49%	5,702 $588,000
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $707,445 - $958,364	5,970 New	5,970 $725,000
Q2 2019 Aug 27, 2019	BUY	$13.7 - $28.34 $307,907 - $636,941	22,475 New	22,475 $329,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of River & Mercantile Asset Management LLP, based on Form 13F filings with the SEC.

Stay updated on River & Mercantile Asset Management LLP with notifications on news.